-
公开(公告)号:US20090291975A1
公开(公告)日:2009-11-26
申请号:US12469438
申请日:2009-05-20
IPC分类号: A61K31/485 , A61P29/00
CPC分类号: A61K31/485 , A61K9/0095 , A61K2300/00
摘要: Provided are pharmaceutical compositions and methods for the alleviation of pain in a patient with optimal ratios of morphine and oxycodone that provide superior analgesic efficacy and lower incidence of adverse side effects compared to morphine and oxycodone alone. The pharmaceutical compositions comprise morphine and oxycodone, or pharmaceutically acceptable salts thereof, in ratios of about 3 to 2 to about 1 to 2, morphine to oxycodone by weight.
摘要翻译: 提供了与吗啡和羟考酮相比,吗啡和羟考酮的最佳比例减轻疼痛的药物组合物和方法,其提供优异的止痛效力和较低的与吗啡和羟考酮相比的不利副作用的发生率。 药物组合物包含约3至2至约1至2的吗啡和羟考酮或其药学上可接受的盐,吗啡与羟考酮的重量比。
-
2.
公开(公告)号:US5489607A
公开(公告)日:1996-02-06
申请号:US389526
申请日:1995-02-16
申请人: Michael A. Breider , Cynthia L. Courtney , Felix A. De La Iglesia , Alexander W. Gough , Alan L. Metz
发明人: Michael A. Breider , Cynthia L. Courtney , Felix A. De La Iglesia , Alexander W. Gough , Alan L. Metz
IPC分类号: A61K31/4025 , A61K31/40 , A61K31/335 , A61K31/34 , A61K31/44 , A61K31/55
CPC分类号: A61K31/4025
摘要: The instant invention is a method of using known compounds, such as (-)-5.alpha.,7.alpha.,-8.beta.-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-4-benzofuranacetamide, as agents for treating benign prostatic hyperplasia.
摘要翻译: 本发明是使用已知化合物的方法,例如( - ) - 5α,7α,-8β-甲基-N- [7-(1-吡咯烷基)-1-氧杂螺[4.5] 8-yl] -4-苯并呋喃乙酰胺作为治疗良性前列腺增生的药物。
-